108 related articles for article (PubMed ID: 18035678)
1. [Prognostic factors in ovarian carcinoma].
Hauptmann S; Köbel M
Verh Dtsch Ges Pathol; 2005; 89():92-100. PubMed ID: 18035678
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors of ovarian cancer].
Ochiai K
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
[TBL] [Abstract][Full Text] [Related]
3. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
7. [Initial surgery in advanced epithelial cancers of the ovary].
Dauplat J; Le Bouëdec G; Pomel C; Kauffmann P
Ann Chir; 1997; 51(10):1058-68. PubMed ID: 10868027
[TBL] [Abstract][Full Text] [Related]
8. [The impact of the pathologist on the treatment of epithelial ovarial cancer].
Zivanovic O; Braun M; Park TW; Kuhn W
Verh Dtsch Ges Pathol; 2005; 89():101-10. PubMed ID: 18035679
[TBL] [Abstract][Full Text] [Related]
9. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors in ovarian carcinoma].
Sliutz G
Wien Med Wochenschr; 1996; 146(1-2):14-7. PubMed ID: 8835490
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of hemoglobin levels before and during carboplatin/taxane-based chemotherapy in patients with primary invasive epithelial ovarian cancer.
Eichbaum MH; Weiss LM; Bruckner T; Schneeweiss A; Sinn HP; Gebauer G; Fersis N; Kussmaul J; Sohn C
Med Sci Monit; 2009 Apr; 15(4):CR156-63. PubMed ID: 19333199
[TBL] [Abstract][Full Text] [Related]
12. Debulking surgery for incompletely operated advanced epithelial ovarian carcinoma.
Gultekin M; Dursun P; Doğan NU; Kolusari A; Yuce K; Ayhan A
J Surg Oncol; 2009 Sep; 100(3):258-60. PubMed ID: 19347889
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma.
Lund B; Williamson P; van Houwelingen HC; Neijt JP
Cancer Res; 1990 Aug; 50(15):4626-9. PubMed ID: 2369738
[TBL] [Abstract][Full Text] [Related]
14. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
Chi DS; Eisenhauer EL; Zivanovic O; Sonoda Y; Abu-Rustum NR; Levine DA; Guile MW; Bristow RE; Aghajanian C; Barakat RR
Gynecol Oncol; 2009 Jul; 114(1):26-31. PubMed ID: 19395008
[TBL] [Abstract][Full Text] [Related]
15. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
Karam AK; Chiang JW; Fung E; Nossov V; Karlan BY
Gynecol Oncol; 2009 Aug; 114(2):246-52. PubMed ID: 19500821
[TBL] [Abstract][Full Text] [Related]
16. Germ cell tumors of the ovary.
Pectasides D; Pectasides E; Kassanos D
Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
[TBL] [Abstract][Full Text] [Related]
17. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.
Gadducci A; Cosio S; Tana R; Genazzani AR
Crit Rev Oncol Hematol; 2009 Jan; 69(1):12-27. PubMed ID: 18595727
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
19. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological prognostic factors of adult granulosa cell tumor of the ovary--a study of 37 cases.
Mehta H; Trivedi P; Parikh B; Shukla K; Shah MJ
Indian J Pathol Microbiol; 2005 Oct; 48(4):439-43. PubMed ID: 16366090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
